Search

Your search keyword '"Rachmilewitz Minei, Tamar"' showing total 9 results
Start Over Author "Rachmilewitz Minei, Tamar" Journal journal of clinical oncology
9 results on '"Rachmilewitz Minei, Tamar"'

1. Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).

Author

Arend, Rebecca C., Monk, Bradley J., Shapira-Frommer, Ronnie, Haggerty, Ashley F., Alvarez, Edwin A., Amit, Amnon, Alvarez Secord, Angeles, Muller, Carolyn, Casado Herraez, Antonio, Herzog, Thomas J., Tewari, Krishnansu S., Cohen, Joshua G., Huang, Marilyn, Yachnin, Adelya, Holeman, Laura L., Ledermann, Jonathan A., Rachmilewitz Minei, Tamar, Buyse, Marc, Fain Shmueli, Shifra, and Lavi, Michal

Published
2024
Full Text
View/download PDF

3. Pivotal study of ofra-vec (VB-111) combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).

Author

Penson, Richard T., primary, Arend, Rebecca Christian, additional, Secord, Angeles Alvarez, additional, Casado Herraez, Antonio, additional, Herzog, Thomas J., additional, Ledermann, Jonathan A., additional, Moore, Kathleen N., additional, Shapira-Frommer, Ronnie, additional, Tewari, Krishnansu Sujata, additional, Rachmilewitz Minei, Tamar, additional, Harats, Dror, additional, Fain Shmueli, Shifra, additional, and Monk, Bradley J., additional

Published
2022
Full Text
View/download PDF

4. Clinical trial in progress: Pivotal study of VB-111 combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).

Author

Arend, Rebecca Christian, primary, Monk, Bradley J., additional, Herzog, Thomas J., additional, Ledermann, Jonathan A., additional, Moore, Kathleen N., additional, Secord, Angeles Alvarez, additional, Shapira-Frommer, Ronnie, additional, Tewari, Krishnansu Sujata, additional, Rachmilewitz Minei, Tamar, additional, Harats, Dror, additional, and Penson, Richard T., additional

Published
2021
Full Text
View/download PDF

5. Clinical trial in progress: Pivotal study of VB-111 combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).

Author

Arend, Rebecca Christian, primary, Monk, Bradley J., additional, Burger, Robert Allen, additional, Herzog, Thomas J., additional, Ledermann, Jonathan A., additional, Moore, Kathleen N., additional, Secord, Angeles Alvarez, additional, Shapira, Roni, additional, Tewari, Krishnansu Sujata, additional, Huang, Marilyn, additional, Amit, Amnon, additional, Rachmilewitz Minei, Tamar, additional, Harats, Dror, additional, and Penson, Richard T., additional

Published
2020
Full Text
View/download PDF

7. Quantitative radiographic analysis of phase II and III trials in recurrent glioblastoma treated with VB-111 with or without bevacizumab or bevacizumab monotherapy.

Author

Ellingson, Benjamin M., primary, Raymond, Catalina, additional, Yao, Jingwen, additional, Chakhoyan, Ararat, additional, Turley, Dallas, additional, Tsung, Joseph, additional, Goldman, Jodi, additional, Schlossman, Jacob, additional, Tan, Caleb, additional, Brenner, Andrew Jacob, additional, Butowski, Nicholas A., additional, Wen, Patrick Y., additional, Rachmilewitz Minei, Tamar, additional, Cohen, Yael Chava, additional, Harats, Dror, additional, and Cloughesy, Timothy Francis, additional

Published
2019
Full Text
View/download PDF

8. Randomized controlled phase III trial of weekly paclitaxel ± ofranergene obadenovec (VB-111) for platinum-resistant ovarian cancer (OVAL Study/GOG 3018).

Author

Arend, Rebecca Christian, Monk, Bradley J., Shapira-Frommer, Ronnie, Secord, Angeles Alvarez, Herzog, Thomas J., Tewari, Krishnansu Sujata, Ledermann, Jonathan A., Rachmilewitz Minei, Tamar, Buyse, Marc E., Haggerty, Ashley, Alvarez, Edwin A, Amit, Amnon, Muller, Carolyn, Casado Herraez, Antonio, Holman, Laura L., Cohen, Joshua, Huang, Marilyn, Yachnin, Adelya, Harats, Dror, and Penson, Richard T.

Published
2023
Full Text
View/download PDF

9. Depth of radiographic response (DpR) and time to tumor regrowth (TTG) to predict overall survival following anti-VEGF therapy in recurrent glioblastoma.

Author

Ellingson, Benjamin M., Hagiwara, Akifumi, Morris, Connor, Cho, Nicholas, Oshima, Sonoko, Sanvito, Francesco, Oughourlian, Talia, Raymond, Catalina, Abrey, Lauren E., Garcia, Josep, Aftab, Dana T., Hessel, Colin, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Nathanson, David, Wen, Patrick Y., and Cloughesy, Timothy Francis

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results